Alterity Therapeutics Limited

Rentabilité sur six mois: +3.53%
Rendement en dividendes: 0%
Secteur: Healthcare

4.4 $

0 $ 0%
1.05 $
4.99 $

paper.min_max_per_year

Calendrier des promotions Alterity Therapeutics Limited

À propos de l'entreprise Alterity Therapeutics Limited

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that is in Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy advance; and PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.

Paramètres de base

IPO date
2002-09-05
ISIN
US02155X1063
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
aud
Сайт

Grade

Sous-estimation
Nom Signification Grade
P/S 4.09 4
P/BV 1.19 9
P/E 0 0
Efficacité
Nom Signification Grade
ROA -82.18 0
ROE -104.47 0
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA -0.0081 10
Debt/Ratio 0.0083 10
Debt/Equity 0.3932 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 876.58 10
Rentabilité Ebitda, % 89.99 9
Rentabilité EPS, % 31034.18 10

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 4.4 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 4.67 $ 0 $ 0 $ -5.78 % 0 % 0 %
common.calendar.number_days.30d 4.25 $ 4.4 $ 4.4 $ +3.53 % 0 % 0 %
common.calendar.number_days.90d 3.14 $ 3.44 $ 4.84 $ +40.35 % 0 % 0 %
common.calendar.number_days.180d 4.25 $ 2.54 $ 4.99 $ +3.53 % 0 % 0 %
common.calendar.number_days.1y 1.51 $ 1.05 $ 4.99 $ +191.39 % 0 % 0 %
common.calendar.number_days.3y 0.6 $ 0.3201 $ 35 $ +633.33 % 0 % 0 %
common.calendar.number_days.5y 1.46 $ 0.3201 $ 35 $ +201.37 % 0 % 0 %
common.calendar.number_days.10y 0.3201 $ 0.3201 $ 35 $ +1 374.57 % 0 % 0 %
common.calendar.number_days.ytd 2.91 $ 2.54 $ 4.99 $ +51.2 % 0 % 0 %

Principaux propriétaires

Entreprises similaires



Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Geoffrey Paul Kempler B.Sc. Co-Founder & Non-Executive Chairman 207.52k 1955 (70 années)
Dr. David A. Stamler M.D. Chief Executive Officer 613.33k 1961 (64 année)
Dr. Rudolph Emile Tanzi Ph.D. Chief Scientific Advisor and Member of Research & Development Advisory Board N/A 1959 (66 années)
Dr. Robert Cherny Head of Research N/A
Mr. Phillip Allen Hains BBus(Acc), C.A., M.B.A. CFO & Company Secretary N/A 1959 (66 années)
Dr. Steven D. Targum M.D. Chief Medical Advisor

Informations sur l'entreprise

Adresse: Australia, Melbourne, 350 Collins Street - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://alteritytherapeutics.com